The JUPITER Trial: Responding to the Critics - 13/08/11
Doi : 10.1016/j.amjcard.2010.08.025
Paul M. Ridker, MD ⁎ 
, Robert J. Glynn, ScD
, Robert J. Glynn, ScD Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts
Corresponding author: Tel: 617-732-8790; fax: 617-734-1508
Le texte complet de cet article est disponible en PDF.
Plan
| Drs. Ridker and Glynn are the principal investigator and the academic study statistician, respectively, of the investigator-initiated Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial, which was funded by AstraZeneca (Wilmington, Delaware). Dr. Ridker is listed as a coinventor on patents held by Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and that have been licensed to Siemens Medical Systems (Erlangen, Germany) and AstraZeneca. During the period of the JUPITER trial project, Dr. Ridker reports having received investigator-initiated research grant support from the National Heart, Lung, and Blood Institute (Bethesda, Maryland), the National Cancer Institute (Bethesda, Maryland), the Donald W. Reynolds Foundation (Las Vegas, Nevada), Fondation Leducq (Paris, France), AstraZeneca, Novartis (Basel, Switzerland), Merck & Company (Whitehouse Station, New Jersey), Abbott Laboratories (Abbott Park, Illinois), Roche Diagnostics GmbH (Mannheim, Germany), and Sanofi-Aventis (Paris, France), and consulting fees and/or lecture fees from AstraZeneca, Novartis, Merck & Company, Merck/Schering-Plough, Sanofi-Aventis, ISIS Pharmaceuticals (Carlsbad, California), Dade-Behring (Deerfield, Illinois), and Vascular Biogenics (Yehuda, Israel). Dr. Glynn reports receiving research grant support from the National Heart, Lung, and Blood Institute, AstraZeneca, and Bristol-Myers Squibb (New York, New York). |
© 2010
Elsevier Inc. Tous droits réservés.
Vol 106 - N° 9
P. 1351-1356 - novembre 2010 Retour au numéro
Article précédent
- Comparison of Left and Right Atrial Volume by Echocardiography Versus Cardiac Magnetic Resonance Imaging Using the Area-Length Method
- Matthew Whitlock, Anuj Garg, Jill Gelow, Timothy Jacobson, Craig Broberg
- Statin Therapy in Primary Prevention: New Insights Regarding Women and the Elderly
- Colleen Harrington, Aaron Horne, Rani K. Hasan, Roger S. Blumenthal
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?